HB
Herborium Group, Inc.
HBRM · OTC
$0.00 +0.00% (+$0.00)
1M +9,900.00%
Market Cap $1.09M
P/E Ratio -
Div. Yield -
ROE 0.77%
Piotroski F-Score Weak
3/9Valuation
87 /100
Cheap P/S 0.98x
P/FCF 2.97x
EV/EBITDA 10.89x
Growth
40 /100
Stable Rev. growth 4.06%
FCF growth N/A
Book val. growth N/A
Profitability
58 /100
Moderate Net margin 2.64%
Op. margin 2.57%
FCF margin 32.88%
Quality
30 /100
Poor ROE 0.77%
ROA 18.89%
Asset turnover 7.16x
Debt
1 /100
High Net debt/EBITDA 5.36x
Current ratio 0.01x
Int. coverage N/A
Stability
48 /100
Moderate Rev. volatility 4.73%
Profitable years 1
Beta 7.24x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about HBRM
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Agnes Olszewski
Employees
2
Headquarters
Sugar Land